GRAYSON KOVAL: Open Payments
NPI 1073048492 · MIDLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,320 in 54 payments from 8 companies in 2025. Trend: 2023 $1,871 · 2024 $1,120 · 2025 $2,320
Food & beverage: $1,540Travel & lodging: $780
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $927 |
| Medtronic, Inc. | 35 | $821 |
| ABBVIE INC. | 3 | $276 |
| Globus Medical, Inc. | 3 | $86 |
| Stryker Corporation | 2 | $73 |
| SI-BONE, INC. | 3 | $61 |
| SPR Therapeutics, Inc | 1 | $59 |
| Curonix LLC | 1 | $17 |
Products named: General - Therapies, INTELLIS ADAPTIVESTIM, SYNCHROMEDII, QULIPTA, UBRELVY, Senza, KYPHON EXPRESS II KYPHOPAK TRAY, ACCURIAN.
Industry payments across TX — which companies pay providers there.
